Cristal Therapeutics
Cristal Therapeutics (formerly Cristal Delivery) is developing the nanomedicines based on its proprietary CriPec platform for cancer and inflammation. The technology platform consists of tunable polymers, biodegradable drug linkers, and targeting ligands that enable the design and development of targeted nanomedicines. Its lead product is CriPec docetaxel for the treatment of solid tumors is in phase 2 trials. The…
Funding snapshot
About
Cristal Therapeutics (formerly Cristal Delivery) is developing the nanomedicines based on its proprietary CriPec platform for cancer and inflammation. The technology platform consists of tunable polymers, biodegradable drug linkers, and targeting ligands that enable the design and development of targeted nanomedicines. Its lead product is CriPec docetaxel for the treatment of solid tumors is in phase 2 trials. The company was founded in 2011 and headquartered in Maastricht, Netherlands. It has raised $21.2M in series b funding, with backing from Europa, Thuja Capital, BioGeneration Ventures, Brightlands Venture Partners, and others. The company operates in the Life Sciences - Drug Delivery, High Tech - Nanotechnology, Life Sciences - Oncology space. Provides nanomedicines based ON CriPec platform for cancer and inflammation disorder.
Business model
Nanotechnology > Nanoenabled Products > Life Science > Drugs > Cancer,
Oncology > Drugs > Diversified,
Drug Delivery > Nanoparticle Based
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.
Raising like Cristal Therapeutics?
Analyze your pitch deck before your next raise.
Analyze My Deck →